| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Pinion John Richard is a See Remarks at RARE. Recent filings cover 0 purchases and 11 sales.
Our model assigns Pinion John Richard a strong insider score of 73/100, based on 7 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +29.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 10,029 | $22.80 | $228,661.20 | -8.4% | - | - | |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 14,439 | $42.10 | $607,881.90 | -11.8% | -12.4% | -46.5% | |
| Mar 1, 2024 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 4,173 | $53.76 | $224,340.48 | -4.5% | -28.0% | -20.1% | |
| May 18, 2023 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 2,012 | $50.00 | $100,600.00 | -2.6% | -27.1% | -17.8% | |
| Mar 1, 2023 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 3,755 | $45.26 | $169,951.30 | -4.5% | +6.0% | +13.3% | |
| Mar 1, 2022 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 4,498 | $66.62 | $299,656.76 | -9.0% | -30.4% | -32.2% | |
| Oct 14, 2021 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 358 | $81.14 | $29,048.12 | -0.7% | -12.1% | -54.2% | |
| May 6, 2021 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 363 | $113.69 | $41,269.47 | -0.7% | -26.2% | -50.3% | |
| Mar 1, 2021 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 6,198 | $138.17 | $856,377.66 | -11.0% | - | - | |
| Oct 14, 2020 | RARE Ultragenyx Pharmaceutical Inc. | See Remarks | Sell | 262 | $88.00 | $23,056.00 | -0.6% | - | - |